Bill > SB0091

This bill modifies existing Indiana law regarding syringe exchange programs, which are operated by "qualified entities" to provide sterile syringes and needles in exchange for used ones, aiming to reduce the spread of diseases. Key provisions include prohibiting these programs from operating fixed sites within 1,000 feet of public schools, nonpublic schools, licensed child care centers, or buildings primarily used for religious worship, unless the operator of that facility gives written approval. The bill also clarifies that programs can still offer overdose intervention drugs, referral and education services, and safe disposal of used syringes at these sites. Furthermore, it amends the duties of qualified entities by requiring them to provide only one sterile syringe and needle in exchange for each used one, and to maintain data on drug treatment referrals and their effectiveness. To participate in a program, individuals must now be residents of specific regions or contiguous counties and present valid identification. The bill also prohibits qualified entities from providing chemical reagents or precursors, which are substances used in the manufacturing of illegal drugs. The state health commissioner is empowered to investigate complaints of noncompliance and can suspend or terminate a program's approval if violations are found, in addition to the existing authority of local bodies to do so. Finally, the expiration date for these syringe exchange programs is extended from July 1, 2026, to July 1, 2031.

Health and Social Services

https://iga.in.gov/legislative/2026/bills/senate/91/details